A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
Year: 1994
Type: article
Source: PubMed
Authors: M Kitagawa, H Higashi, I S Takahashi, T Okabe, H Ogino, Y Taya, S Hishimura, A Okuyama
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2409913804
